Patricia Brooks is a member of Gowling WLG's Toronto office, practising primarily in areas of law related to pharmaceuticals and health care.
Patti's practice focuses on the regulation and pricing of drugs, biologicals and radiopharmaceuticals, and medical devices. This includes work related to development of drugs and devices from pre-clinical, clinical testing and post-marketing phases, including clinical trial agreements and protocols, research agreements, and advertising and promotion of drugs and devices to health care professionals and consumers. She also assists clients with matters relating to the Patented Medicine Prices Review Board, provincial drug benefits formulary matters (including formulary 'listing' issues), and private insurance funding and reimbursement of drug and device costs.
Patti is also a registered Canadian patent agent, with experience in patent prosecution, performing freedom-to-operate analyses, and providing patent validity and infringement opinions. She has appeared before the Federal Court of Canada and the Health Professions Appeal and Review Board.
While at law school, Patti was awarded the Samuel and Clara Shime Prize for Achievement in Law and Medicine. She also volunteered with Pro Bono Students Canada, working for both the Health Professions Appeal and Review Board and the Medico-Legal Society of Toronto.
Prior to attending law school, Patti was a postdoctoral fellow at the Tanz Centre for Research in Neurodegenerative Diseases at the University of Toronto. Her research focused on molecular and cellular changes in Parkinson's and Alzheimer's disease.
Patti completed a Ph.D. in neurophysiology at the University of Toronto, examining the neurochemical control of muscle activity in sleep. She obtained her M.Sc. and B.Sc.H. in biology from Queen's University. Patti has published numerous scientific articles related to her research.